Treating Psoriatic Arthritis with Biological Disease Modifying Antirheumatic Drugs: Systematic Review and Meta-Analysis to Evaluate Efficacy and Safety

Antirheumatic Drugs ◽

Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis

Clinical Rheumatology ◽

10.1007/s10067-021-05622-w ◽

2021 ◽

Author(s):

Mariana Garcia-Leal ◽

Mayra A. Reyes-Soto ◽

Ivan Hernandez-Galarza ◽

Neri A. Alvarez-Villalobos ◽

Dionicio A. Galarza-Delgado ◽

...

Keyword(s):

Systematic Review ◽

Psoriatic Arthritis ◽

Radiographic Progression ◽

Meta Analysis ◽

Current Evidence ◽

Antirheumatic Drugs ◽

Risk of Hepatitis B Virus Reactivation in Patients With Inflammatory Arthritis Receiving Disease-Modifying Antirheumatic Drugs: A Systematic Review and Meta-Analysis

Arthritis Care & Research ◽

10.1002/acr.23346 ◽

2018 ◽

Vol 70 (5) ◽

pp. 724-731 ◽

Cited By ~ 11

Author(s):

Tzu-Chieh Lin ◽

Kazuki Yoshida ◽

Sara K. Tedeschi ◽

Mirhelen Mendes de Abreu ◽

Nikroo Hashemi ◽

...

Keyword(s):

Systematic Review ◽

Hepatitis B Virus ◽

Inflammatory Arthritis ◽

Meta Analysis ◽

Virus Reactivation ◽

Antirheumatic Drugs ◽

Hepatitis B Virus Reactivation ◽

B Virus ◽

THU0441 Effect of Concomitant Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) on The Efficacy and Safety of Ixekizumab in Biologic Dmard-Naive Patients with Active Psoriatic Arthritis

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2016-eular.1399 ◽

2016 ◽

Vol 75 (Suppl 2) ◽

pp. 350-351 ◽

Cited By ~ 2

Author(s):

L.C. Coates ◽

A.B. Gottlieb ◽

C.L. Shuler ◽

C.-Y. Lin ◽

S. Samanta ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Efficacy And Safety ◽

Antirheumatic Drugs ◽

Biologic Dmard ◽

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis

BMJ ◽

10.1136/bmj.i1777 ◽

2016 ◽

pp. i1777 ◽

Cited By ~ 80

Author(s):

Glen S Hazlewood ◽

Cheryl Barnabe ◽

George Tomlinson ◽

Deborah Marshall ◽

Dan Devoe ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Combination Therapy ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Cochrane Systematic Review ◽

Effects of Biologic Agents and Other Disease-Modifying Antirheumatic Drugs on Cardiovascular Outcomes in Psoriasis and Psoriatic Arthritis: A Systematic Review

Current Pharmaceutical Design ◽

10.2174/138161282004140213123505 ◽

2014 ◽

Vol 20 (4) ◽

pp. 500-512 ◽

Cited By ~ 26

Author(s):

April Armstrong ◽

Elizabeth Brezinski ◽

Matthew Follansbee ◽

Ehrin Armstrong

Keyword(s):

Systematic Review ◽

Psoriatic Arthritis ◽

Cardiovascular Outcomes ◽

Biologic Agents ◽

Antirheumatic Drugs ◽

Comparative Risk of Cardiovascular Events With Biologic and Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

Arthritis Care & Research ◽

10.1002/acr.23875 ◽

2020 ◽

Vol 72 (4) ◽

pp. 561-576 ◽

Cited By ~ 19

Author(s):

Siddharth Singh ◽

Mathurin Fumery ◽

Abha G. Singh ◽

Namrata Singh ◽

Larry J. Prokop ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Cardiovascular Events ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Comparative Risk ◽

Assessing the effectiveness of synthetic and biologic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review

Psoriasis Targets and Therapy ◽

10.2147/ptt.s52893 ◽

2015 ◽

pp. 71 ◽

Cited By ~ 3

Author(s):

Gabrielle Kingsley ◽

David Scott

Keyword(s):

Systematic Review ◽

Psoriatic Arthritis ◽

Antirheumatic Drugs ◽

THU0196 Systematic review and meta-analysis of malignancies, excluding non-melanoma skin cancer, in patients with rheumatoid arthritis treated with tofacitinib or biologic disease-modifying antirheumatic drugs

10.1136/annrheumdis-2017-eular.1960 ◽

2017 ◽

Author(s):

JJ Gomez-Reino ◽

T Checchio ◽

J Geier ◽

M Boy ◽

S Ahadieh ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Skin Cancer ◽

Meta Analysis ◽

Antirheumatic Drugs ◽

Non Melanoma Skin Cancer ◽

Disease Modifying ◽

Melanoma Skin

OP0216 Efficacy and safety of tofacitinib, an oral janus kinase inhibitor, or adalimumab in patients with active psoriatic arthritis and an inadequate response to conventional synthetic disease-modifying antirheumatic drugs (CSDMARDS): a randomised, placebo-controlled, phase 3 trial

10.1136/annrheumdis-2017-eular.1416 ◽

2017 ◽

Cited By ~ 2

Author(s):

PJ Mease ◽

S Hall ◽

O FitzGerald ◽

D van der Heijde ◽

JF Merola ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Kinase Inhibitor ◽

Janus Kinase ◽

Inadequate Response ◽

Efficacy And Safety ◽

Antirheumatic Drugs ◽

Phase 3 ◽

Janus Kinase Inhibitor ◽

PMS5 Comparative Efficacy of Filgotinib Versus Alternative Treatments for Rheumatoid Arthritis in Patients with an Inadequate Response to Biologic Disease-Modifying Antirheumatic Drugs: A Systematic Review and Network Meta-Analysis

Value in Health ◽

10.1016/j.jval.2020.08.1136 ◽

2020 ◽

Vol 23 ◽

pp. S592-S593

Author(s):

I. Jacob ◽

L. Beresford ◽

K. Butler ◽

B. McNamara ◽

J. Dennis ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Meta Analysis ◽

Inadequate Response ◽

Comparative Efficacy ◽

Alternative Treatments ◽

Antirheumatic Drugs ◽